Dallas, Texas, United states, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Global Respiratory Pathogen Testing Kits Market was valued at US$2.49 Bn in 2019 up by 5% over 2018. The market will witness a substantial CAGR of 6.5% between 2020 and 2027.
Respiratory Pathogen Panel Kit means an in vitro diagnostic test for the qualitative finding of following microorganisms from respiratory samples and bacterial/viral cultures using Real Time PCR method. On amplification of conserved region of the microbial genome this Kit is based. There is a multiplexing reaction running in parallel in each tube to notice different targets with the help of four different dyes.
Request a Sample Copy of the Research Report: https://qualiketresearch.com/request-sample/Respiratory-Pathogen-Kits-Market/request-sample
Key Players
Various key players are discussed in this report such as Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Biomérieux, Alere Inc, Bio-Rad Laboratories, Inc., Cosmed, and Seegene Inc
Impact of the COVID-19
The outbreak of pandemic has strengthened the market as the number of cases are increasing every single day at an alarming rate. To employ corrective measures in the specified timeframe; it is overbearing to have respiratory pathogen testing kits in place. Top companies along with government bodies are coming together to keep pace with regards to these kits availability.
Regional Analysis
North America and Europe jointly account for around 55% market share currently and the position quo is unlikely to change during the forecast period. Asia Pacific is fastest growing region as many companies are opting for strategic expansion because of the ever-increasing incidences of pathogen-centric diseases. Some of them are also tying up with local players to report the growing demand and provide affordable kits.
Buy Respiratory Pathogen Testing Kits Market: https://qualiketresearch.com/paymentgateway/Respiratory-Pathogen-Kits-Market/payment-gateway
Key Development
November 2021 Philips advances ultrasound portfolio with new robust imaging tools and features for Radiology to increase diagnostic confidence and workflow efficiency.
November 2021 ABBOTT announced the launch of Similac 360 Total Care, the company's next generation of infant formula with HMOs, major prebiotics structurally identical to those found in human breast milk.
Market Segmentation
By Test Type
- Pulmonary Function Tests
- OSA Diagnostic Tests
- Imaging Tests
- Traditional Diagnostic Tests
- Molecular Diagnostic Tests
- Others
By Diseases
- Tuberculosis
- Asthma
- Lung Cancer
- Chronic Obstructive Pulmonary Diseases
- Others
By End User
- Hospital Clinical Laboratories
- Reference laboratories
- Physician Offices
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Get your Customized Research Report: https://qualiketresearch.com/request-sample/Respiratory-Pathogen-Kits-Market/ask-for-customization
About Us
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.
